News

ModMed Named Leader in G2 Fall 2023 Grid® Report for its EHR Software

The healthcare technology leader earned 7 badges in G2's fall report, including Mid-Market and Small Business LeaderBOCA RATON, Fla.--(BUSINESS WIRE)--ModMed®…

2 years ago

CitiusTech Appoints Sudhir Kesavan as Chief Operating Officer

PRINCETON, N.J.--(BUSINESS WIRE)--#COO--CitiusTech, a leading provider of healthcare technology services, solutions, and platforms, announced the appointment of Sudhir Kesavan as…

2 years ago

B-Secur Receives ISO 13485:2016 Certification

BELFAST, Northern Ireland--(BUSINESS WIRE)--#BiosensingInnovation--B-Secur, a global leader in biosensing algorithms, today announced that it has received ISO 13485:2016, the Quality…

2 years ago

Cannabinoid Biotech Leader FloraWorks to Present at Seed Showcase 2024 During J.P. Morgan Healthcare Conference

CEO Alleh Lindquist to Present the Company's Breakthrough Cannabinoid Research Approach For a New Generation of TherapeuticsPortland, Oregon--(Newsfile Corp. -…

2 years ago

Healthcare Industry Veteran Donald M. Casey Jr. Joins Board of Directors at Cannabinoid Biotech Leader FloraWorks

Portland, Oregon--(Newsfile Corp. - January 4, 2024) - FloraWorks Holdings Inc., a leading cannabinoid biotech company, announced the appointment of…

2 years ago

Issuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs)

New patent issued for core rare disease target indication for crofelemerJaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the…

2 years ago

NanoViricides to Present at the Biotech Showcase in San Fransisco

SHELTON, CT / ACCESSWIRE / January 4, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development…

2 years ago

Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Officer

CELEBRATION, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics…

2 years ago

RespireRx Pharmaceuticals Inc. Announces the Publication of a Case Report in which KRM-II-81 Totally Suppressed Epileptiform Activity in Brain Tissue Surgically Removed from Epileptic Patient

Glen Rock, N.J., Jan. 04, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the “Company”),…

2 years ago